Waiting
로그인 처리 중...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Etablering og karakterisering af tre…
JoVE Journal
Cancer Research

JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다. 전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.

JoVE Journal Cancer Research
Etablering og karakterisering af tre Afatinib-resistente lunge adenokarcinom PC-9 cellelinjer udviklet med stigende doser Afatinib
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Journal (Cancer Research)
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Journal (Cancer Research)
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
 
Click here for the English version

Etablering og karakterisering af tre Afatinib-resistente lunge adenokarcinom PC-9 cellelinjer udviklet med stigende doser Afatinib

Article DOI: 10.3791/59473-v • 09:38 min • June 26th, 2019
June 26th, 2019 •
1, 1, 2, 1, 3
1Advanced Cancer Translational Research Institute, Showa University, 2Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, 3Division of Allergology and Respiratory Medicine, Department of Medicine, Showa University School of Medicine

챕터

요약
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

En metode til at etablere afatinib-resistens cellelinjer fra lunge adenokarcinom PC-9 celler blev udviklet, og resistente celler blev karakteriseret. De resistente celler kan bruges til at undersøge epidermal vækstfaktor receptor tyrosinkinase hæmmer-resistensmekanismer, der gælder for patienter med ikke-småcellet lungekræft.

Tags

Kræftforskning trinvis dosisoptrapning lægemiddelresistens EGFR-aktiverende mutationer EGFR-TKI afatinib lungekræft
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter